BioCentury | Oct 8, 2019
Company News

Management tracks: BioMarin's first chief scientific strategy officer; plus Ascletis, Grail, Aerie and more

...and Co. (NYSE:LLY). Gregory is chair and CEO of Isometry Advisors Inc. Therapeutic toxin company Aeon Biopharma Inc....
...Writer BioMarin Pharmaceutical Inc. Ascletis Pharma Inc. Grail Inc. Aerie Pharmaceuticals Inc. Verrica Pharmaceuticals Inc. Biodesix Inc. Nurix Therapeutics Inc. Alphaeon Corp. Relay Therapeutics Inc. Aeon Biopharma Inc....
BioCentury | May 14, 2019
Company News

Management tracks: DBV, Beam, Aeon Biopharma

...Mass.). Alphaeon Corp. (Irvine, Calif.) hired Marc Forth as president and CEO of its new Aeon Biopharma Inc....
Items per page:
1 - 2 of 2
BioCentury | Oct 8, 2019
Company News

Management tracks: BioMarin's first chief scientific strategy officer; plus Ascletis, Grail, Aerie and more

...and Co. (NYSE:LLY). Gregory is chair and CEO of Isometry Advisors Inc. Therapeutic toxin company Aeon Biopharma Inc....
...Writer BioMarin Pharmaceutical Inc. Ascletis Pharma Inc. Grail Inc. Aerie Pharmaceuticals Inc. Verrica Pharmaceuticals Inc. Biodesix Inc. Nurix Therapeutics Inc. Alphaeon Corp. Relay Therapeutics Inc. Aeon Biopharma Inc....
BioCentury | May 14, 2019
Company News

Management tracks: DBV, Beam, Aeon Biopharma

...Mass.). Alphaeon Corp. (Irvine, Calif.) hired Marc Forth as president and CEO of its new Aeon Biopharma Inc....
Items per page:
1 - 2 of 2